Tarantino G - Search Results

1

Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study.

Crocetto F, Barone B, Manfredi C, Trama F, Romano L, Romeo M, Russo G, Sicignano E, Persico F, Aveta A, Spirito L, Napolitano L, Imbimbo C, Tarantino G. Crocetto F, et al. Among authors: tarantino g. J Physiol Pharmacol. 2022 Feb;73(1). doi: 10.26402/jpp.2022.1.05. Epub 2022 May 27. J Physiol Pharmacol. 2022. PMID: 35639037 Free article.

2

Silent non-alcoholic fatty liver disease-a clinical-histological study.

Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML, Vecchione R, Gargiulo G, Gennarelli N, Lobello R. Sorrentino P, et al. Among authors: tarantino g. J Hepatol. 2004 Nov;41(5):751-7. doi: 10.1016/j.jhep.2004.07.010. J Hepatol. 2004. PMID: 15519647

3

A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease.

Sorrentino P, Tarantino G, Perrella A, Micheli P, Perrella O, Conca P. Sorrentino P, et al. Among authors: tarantino g. Dig Dis Sci. 2005 Jun;50(6):1130-5. doi: 10.1007/s10620-005-2719-1. Dig Dis Sci. 2005. PMID: 15986869

4

Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis.

Tarantino G, Conca P, Coppola A, Vecchione R, Di Minno G. Tarantino G, et al. Eur J Clin Invest. 2007 Jan;37(1):48-53. doi: 10.1111/j.1365-2362.2007.01745.x. Eur J Clin Invest. 2007. PMID: 17181567

5

Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.

Tarantino G, Saldalamacchia G, Conca P, Arena A. Tarantino G, et al. J Gastroenterol Hepatol. 2007 Mar;22(3):293-303. doi: 10.1111/j.1440-1746.2007.04824.x. J Gastroenterol Hepatol. 2007. PMID: 17295757 Review.

6

A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease.

Tarantino G, Conca P, Basile V, Gentile A, Capone D, Polichetti G, Leo E. Tarantino G, et al. Hepatol Res. 2007 Jun;37(6):410-5. doi: 10.1111/j.1872-034X.2007.00072.x. Hepatol Res. 2007. PMID: 17539815

7

Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease.

Tarantino G, Marra M, Contaldo F, Pasanisi F. Tarantino G, et al. Clin Invest Med. 2008;31(1):E24-9. doi: 10.25011/cim.v31i1.3138. Clin Invest Med. 2008. PMID: 18312746

8

Non-alcoholic fatty liver disease, obesity and other illnesses.

Tarantino G. Tarantino G. Clin Invest Med. 2008 Oct 1;31(5):E290-5. doi: 10.25011/cim.v31i5.4876. Clin Invest Med. 2008. PMID: 18980719 Review.

9

High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.

Di Minno MN, Tufano A, Rusolillo A, Di Minno G, Tarantino G. Di Minno MN, et al. Among authors: tarantino g. World J Gastroenterol. 2010 Dec 28;16(48):6119-22. doi: 10.3748/wjg.v16.i48.6119. World J Gastroenterol. 2010. PMID: 21182227 Free PMC article.

10

Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease.

Tarantino G, Colao A, Capone D, Conca P, Tarantino M, Grimaldi E, Chianese D, Finelli C, Contaldo F, Scopacasa F, Savastano S. Tarantino G, et al. Among authors: tarantino m. J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):47-56. J Biol Regul Homeost Agents. 2011. PMID: 21382273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters